These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Development of repeated myocardial necrosis in animals with an ischemic infarct following exposure to an antigen from necrotic cardiac muscle]. Fatenkov VN; Pechenina NV Patol Fiziol Eksp Ter; 1978; (4):6-9. PubMed ID: 704164 [No Abstract] [Full Text] [Related]
4. Antigenic properties of the damaged heart muscle. Szabó S; Maros T; Lukács E; Ionescu M; Muntyán G Z Immunitatsforsch Allerg Klin Immunol; 1969 May; 137(5):492-500. PubMed ID: 4239402 [No Abstract] [Full Text] [Related]
5. [Immune damage to the heart and blood vessels]. Moĭbenko AA; Butenko GM Fiziol Zh (1978); 1981; 27(5):587-94. PubMed ID: 7297706 [No Abstract] [Full Text] [Related]
6. Prevention of gross myocardial infarction in the canine heart. Ginks W; Ross J; Sybers HD Arch Pathol; 1974 Jun; 97(6):380-4. PubMed ID: 4825101 [No Abstract] [Full Text] [Related]
7. [Changes in catecholamine concentration and myocardial contractility in focal cytotoxic lesions of the heart]. Buriakov IE Fiziol Zh (1978); 1981; 27(6):780-5. PubMed ID: 7319074 [No Abstract] [Full Text] [Related]
8. [Effect of the antihistaminic preparation fencarol on cardio- and hemodynamics and the energy processes in the myocardium in an infarct-like immune lesion of the heart]. Moĭbenko AA; Frantsuzova SB; Sagach VF; Korkach VI; Sirotina MF Farmakol Toksikol; 1982; 45(6):28-32. PubMed ID: 6129997 [TBL] [Abstract][Full Text] [Related]
10. [Model of reinfarction of the myocardium in animals and characteristics of electrocardiographic changes]. Eĭdinov IaB Vrach Delo; 1967; 9():36-9. PubMed ID: 5621776 [No Abstract] [Full Text] [Related]
11. [Functional and morphological research on the protective action of Neoton in immune heart damage]. Moĭbenko AA; Marchenko GI; Popovich LF Fiziol Zh (1978); 1987; 33(5):54-63. PubMed ID: 3691871 [No Abstract] [Full Text] [Related]
12. [Modeling and experimental therapy of myocardial infarct in dogs]. Maksimovich IaB; Aksel'rod LB; Legeda EA; Gaĭdenko AI; Lukashenko AA Fiziol Zh; 1978; 24(3):331-7. PubMed ID: 658492 [No Abstract] [Full Text] [Related]
13. Distribution of cytosolic and mitochondrial aspartate aminotransferase in normal, ischemic, and necrotic myocardium. An immunohistochemical study. Siegel RJ; Edwalds G; Rej R; Fishbein MC Lab Invest; 1984 Dec; 51(6):648-54. PubMed ID: 6389975 [TBL] [Abstract][Full Text] [Related]
14. [The effect of the duration of coronary occlusion on the healing of an experimental myocardial infarct]. Syroïd DV; Sokrut VM; Shvyrenko IR Fiziol Zh (1994); 1999; 45(6):26-30. PubMed ID: 10687078 [TBL] [Abstract][Full Text] [Related]
15. [Animal experimental immunohistological studies of the postmyocardial infarct syndrome]. Roschlau G; Schuh D Acta Biol Med Ger; 1967; 19(2):339-42. PubMed ID: 4873543 [No Abstract] [Full Text] [Related]
18. Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size. Reimer KA; Jennings RB Lab Invest; 1984 Dec; 51(6):655-66. PubMed ID: 6503220 [TBL] [Abstract][Full Text] [Related]
19. [Use of beta-adrenoreceptor blockade to increase the information value of indices of contractility during evaluation of the functional state of the myocardium]. Kaz'min SG; Korkushko OV; Sagach VF; Shablovskaia OV; Moroz GZ Fiziol Zh (1978); 1986; 32(1):72-5. PubMed ID: 3956786 [No Abstract] [Full Text] [Related]
20. Rat model for acute myocardial infarction: application to technetium-labeled glucoheptonate, tetracycline, and polyphosphate. Adler N; Camin LL; Shulkin P J Nucl Med; 1976 Mar; 17(3):203-7. PubMed ID: 1249630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]